Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries PepGen Inc. - Common Stock (NQ: PEPG ) 17.30 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 11, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 17.30 Bid (Size) 6.920 (2) Ask (Size) 27.50 (1) Prev. Close 17.30 Today's Range 17.30 - 17.30 52wk Range 3.720 - 18.72 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News PepGen Appoints Afsaneh Mohebbi, Ph.D., as SVP, Portfolio and Program Management and Dave Borah, CFA, as SVP, Investor Relations and Corporate Communications July 02, 2024 From PepGen Inc. Via Business Wire PepGen Announces Executive Team Promotions June 11, 2024 From PepGen Inc. Via Business Wire Performance YTD +144.01% +144.01% 1 Month -3.46% -3.46% 3 Month +36.11% +36.11% 6 Month +148.56% +148.56% 1 Year +103.77% +103.77% More News Read More PEPG Stock Earnings: PepGen Beats EPS for Q1 2024 May 14, 2024 Via InvestorPlace PepGen Reports First Quarter 2024 Financial Results and Recent Corporate Highlights May 14, 2024 From PepGen Inc. Via GlobeNewswire PEPG Stock Earnings: PepGen Beats EPS for Q4 2023 March 06, 2024 Via InvestorPlace PepGen: Q3 Earnings Insights November 08, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session April 12, 2024 Via Benzinga Insiders Buying GameStop And 2 Other Stocks April 10, 2024 Via Benzinga PepGen to Participate in Upcoming Investor Conferences March 13, 2024 From PepGen Inc. Via GlobeNewswire PepGen Receives U.S. FDA Orphan Drug and Rare Pediatric Disease Designations for PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy March 13, 2024 From PepGen Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Intraday Session March 07, 2024 Via Benzinga PepGen Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developments March 06, 2024 From PepGen Inc. Via GlobeNewswire PepGen Announces Clearance of CTA by UK Medicines & Healthcare Products Regulatory Agency to Begin CONNECT2-EDO51, a Phase 2 Clinical Trial designed to support potential accelerated approval of PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy March 04, 2024 From PepGen Inc. Via GlobeNewswire PepGen Receives U.S. FDA Fast Track Designation for PGN-EDODM1 for the Treatment of Myotonic Dystrophy Type 1 February 20, 2024 From PepGen Inc. Via GlobeNewswire Over $37M Bet On This Industrial Stock? Check Out These 4 Stocks Insiders Are Buying February 14, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session February 07, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session February 07, 2024 Via Benzinga PepGen Announces Pricing of $80.1 Million Underwritten Offering of Common Stock February 07, 2024 From PepGen Inc. Via GlobeNewswire PepGen soars on Sarepta Therapeutics’ Duchenne drug phase 2 data February 06, 2024 Via MarketBeat Top 4 Health Care Stocks That May Crash This Quarter February 02, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session January 30, 2024 Via Benzinga Mary Beth DeLena Joins PepGen as General Counsel and Secretary January 17, 2024 From PepGen Inc. Via GlobeNewswire PepGen Announces First Patient Dosed in CONNECT1-EDO51 Phase 2 Clinical Trial of PGN-EDO51 for Duchenne Muscular Dystrophy Patients Amenable to Exon 51 Skipping January 08, 2024 From PepGen Inc. Via GlobeNewswire PepGen Announces First Patient Dosed in Phase 1 FREEDOM-DM1 Clinical Trial of PGN-EDODM1 for Myotonic Dystrophy Type 1 (DM1) December 18, 2023 From PepGen Inc. Via GlobeNewswire PepGen Announces Appointment of Howard Mayer, M.D. to Board of Directors November 15, 2023 From PepGen Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
